 Hypothesis 2- This study will provide proof-of-concept data, including event rates, from which to design a larger randomized control trial to assess whether an alert-based CDS strategy will reduce the frequency of stroke and systemic embolism in at-risk patients with nonvalvular AF or atrial flutter. 